Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

2023 Annual Meeting | C67 - Clinical EMG 2: Case-based Clinical Applications of Nerve Conduction Studies and Needle Electromyography

Sunday 04/23/23
03:30 PM - 05:30 PM EST Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Ruple S. Laughlin, MD, FÂé¶¹´«Ã½Ó³»­
Neuromuscular and Clinical Neurophysiology (EMG)
Through this case-based session, participants should be able to demonstrate how to approach a neuromuscular patient electrodiagnostically and utilize nerve conduction studies and needle examination to: evaluate a weak patient to discern myopathy, neuromuscular junction, or motor neuron disorders; distinguish characteristics of peripheral neuropathy; and elucidate EDX findings in mononeuropathies and radiculopathies. The program will build upon electrodiagnostic knowledge acquired in Clinical EMG I.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice
Intermediate
Advanced Practice Provider
Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student
Case-based, Audience Participation
Event Timeline
03:30 PM - 03:35 PM EST Introduction Introduction
Ruple S. Laughlin, MD, FÂé¶¹´«Ã½Ó³»­
03:35 PM - 04:05 PM EST Speaker EDX Case-Based Approach to Weakness
Ruple S. Laughlin, MD, FÂé¶¹´«Ã½Ó³»­
04:05 PM - 04:45 PM EST Speaker Peripheral Neuropathy: Electrodiagnostic Cases
Kelly G. Gwathmey, MD
04:45 PM - 05:20 PM EST Speaker EDX Cases: Plexopathies and Radiculopathies- How EDX Can Help
Devon I. Rubin, MD, FÂé¶¹´«Ã½Ó³»­
05:20 PM - 05:30 PM EST Discussion Questions and Answers
Devon I. Rubin, MD, FÂé¶¹´«Ã½Ó³»­, Ruple S. Laughlin, MD, FÂé¶¹´«Ã½Ó³»­, Kelly G. Gwathmey, MD
Faculty Disclosures
Ruple S. Laughlin, MD, FÂé¶¹´«Ã½Ó³»­ Dr. Laughlin has nothing to disclose.
Devon I. Rubin, MD, FÂé¶¹´«Ã½Ó³»­ Dr. Rubin has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neurophysiology. Dr. Rubin has received intellectual property interests from a discovery or technology relating to health care. Dr. Rubin has received intellectual property interests from a discovery or technology relating to health care. Dr. Rubin has received publishing royalties from a publication relating to health care. Dr. Rubin has received publishing royalties from a publication relating to health care.
Kelly G. Gwathmey, MD Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Strongbridge. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Gwathmey has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cabaletta. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals.